Enfusion Historical Income Statement
| ENFN Stock | USD 11.48 0.16 1.41% |
Historical analysis of Enfusion income statement accounts such as Depreciation And Amortization of 12.1 M or Interest Expense of 2 M can show how well Enfusion performed in making a profits. Evaluating Enfusion income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Enfusion's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Enfusion latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Enfusion is a good buy for the upcoming year.
Enfusion |
About Enfusion Income Statement Analysis
Enfusion Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Enfusion shareholders. The income statement also shows Enfusion investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Enfusion Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Total Revenue
Total revenue comprises all receipts Enfusion generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Enfusion's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Enfusion current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.At this time, Enfusion's EBIT is very stable compared to the past year. As of the 1st of March 2025, Research Development is likely to grow to about 44.2 M, while Tax Provision is likely to drop about 867 K.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 413K | 1.6M | 1.9M | 2.0M | Depreciation And Amortization | 6.6M | 10.0M | 11.5M | 12.1M |
Enfusion income statement Correlations
Click cells to compare fundamentals
Enfusion Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Enfusion income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 433K | 579K | 1.1M | 1.4M | 1.6M | 867.0K | |
| Net Interest Income | (1.7M) | (4.6M) | 413K | 1.6M | 1.9M | 2.0M | |
| Depreciation And Amortization | 2.3M | 4.0M | 6.6M | 10.0M | 11.5M | 12.1M | |
| Interest Expense | 1.7M | 4.6M | 413K | 1.6M | 1.9M | 2.0M | |
| Selling General Administrative | 35.9M | 150.6M | 68.8M | 64.6M | 74.3M | 74.0M | |
| Selling And Marketing Expenses | 9.9M | 51.7M | 29.3M | 20.4M | 23.5M | 26.1M | |
| Total Revenue | 79.6M | 111.7M | 150.3M | 174.5M | 200.7M | 126.5M | |
| Gross Profit | 58.2M | 79.9M | 103.2M | 116.9M | 134.4M | 88.1M | |
| Other Operating Expenses | 73.5M | 387.6M | 162.3M | 162.6M | 187.0M | 182.8M | |
| Operating Income | 6.1M | (275.9M) | (12.0M) | 11.9M | 10.8M | 11.3M | |
| Net Income From Continuing Ops | 4.1M | (282.2M) | (13.3M) | 9.1M | 8.2M | 8.6M | |
| Ebit | 6.1M | (275.9M) | (12.2M) | 11.9M | 10.8M | 11.3M | |
| Research Development | 6.3M | 153.4M | 17.2M | 19.9M | 22.9M | 44.2M | |
| Ebitda | 8.4M | (271.9M) | (5.6M) | 21.9M | 19.7M | 20.7M | |
| Cost Of Revenue | 21.4M | 31.8M | 47.1M | 57.6M | 66.3M | 38.5M | |
| Total Operating Expenses | 52.1M | 355.7M | 115.2M | 104.9M | 120.7M | 144.4M | |
| Reconciled Depreciation | 2.3M | 4.0M | 6.3M | 8.2M | 9.4M | 4.8M | |
| Income Before Tax | 4.5M | (281.7M) | (12.2M) | 11.5M | 10.3M | 10.9M | |
| Total Other Income Expense Net | (1.6M) | (5.8M) | (225K) | (464K) | (533.6K) | (560.3K) | |
| Net Income | 4.1M | (282.2M) | (13.3M) | 6.0M | 5.4M | 5.7M | |
| Income Tax Expense | 433K | 579K | 1.1M | 2.2M | 2.6M | 2.7M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share | Quarterly Revenue Growth 0.154 | Return On Assets |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.